Boditech Med Inc. Logo

Boditech Med Inc.

Develops & manufactures rapid point-of-care in-vitro diagnostic solutions for medical pros.

206640 | KO

Overview

Corporate Details

ISIN(s):
KR7206640005
LEI:
Country:
South Korea
Address:
강원도 춘천시 동내면 거두단지1길 43 -, 춘천시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Boditech Med Inc. is a global in-vitro diagnostics (IVD) company that develops, manufactures, and distributes diagnostic solutions. The company specializes in immune-diagnosis and molecular diagnosis technologies to provide reliable point-of-care testing (POCT) for healthcare professionals. Its product portfolio features a range of instruments and diagnostic reagents, such as the ichroma™ immunoassay platform, designed to deliver rapid and accurate results from simplified samples, including finger-tip whole blood. Boditech Med's solutions support the diagnosis and monitoring of various conditions across multiple medical fields, including cardiology, oncology, infectious diseases, and hormone analysis. The company's mission is to enhance the quality of life globally by making advanced diagnostics accessible anywhere, anytime.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-01 00:00
Regulatory Filings
[기재정정]유형자산취득결정(자율공시)
Korean 11.4 KB
2025-08-29 00:00
Regulatory Filings
유형자산취득결정(자율공시)
Korean 7.5 KB
2025-08-27 00:00
Transaction in Own Shares
주요사항보고서(자기주식취득신탁계약체결결정)
Korean 33.3 KB
2025-08-18 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.1 KB
2025-08-14 00:00
Interim / Quarterly Report
반기보고서 (2025.06)
Korean 2.6 MB
2025-08-08 00:00
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
Korean 16.5 KB
2025-06-23 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.0 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 2.8 MB
2025-05-15 00:00
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
Korean 25.3 KB
2025-05-08 00:00
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
Korean 16.5 KB
2025-04-29 00:00
Share Issue/Capital Change
주식매수선택권부여에관한신고
Korean 15.6 KB
2025-04-14 00:00
Transaction in Own Shares
신탁계약해지결과보고서
Korean 19.4 KB
2025-03-31 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.2 KB
2025-03-28 00:00
Notice of Dividend Amount
배당락
Korean 3.5 KB
2025-03-25 00:00
AGM Information
정기주주총회결과
Korean 24.1 KB

Automate Your Workflow. Get a real-time feed of all Boditech Med Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Boditech Med Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Boditech Med Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Entero Therapeutics, Inc. Logo
Develops targeted oral therapies for a range of gastrointestinal (GI) diseases.
United States of America
ENTO
Entrada Therapeutics, Inc. Logo
Developing intracellular therapeutics for rare neuromuscular diseases via its EEV™ platform.
United States of America
TRDA
Develops novel therapeutics and APIs for oncology, inflammation, and respiratory diseases.
South Korea
183490
Enzymatica AB Logo
Develops medical devices with patented enzyme technology to treat upper respiratory infections.
Sweden
ENZY
Epitomee Medical Ltd. Logo
Develops ingestible therapeutic devices for weight management and targeted drug delivery.
Israel
EPIT
EQL Pharma AB Logo
Develops and sells cost-efficient niche generic medicines for the Nordic healthcare market.
Sweden
EQL
Erasca, Inc. Logo
Clinical-stage oncology company developing therapies targeting the RAS/MAPK pathway in cancer.
United States of America
ERAS
Ernexa Therapeutics Inc. Logo
Developing targeted, off-the-shelf cell therapies for cancer and autoimmune diseases.
United States of America
ERNA
ERYTECH Pharma S.A. Logo
Developing phage therapies to combat antibiotic-resistant bacterial infections.
France
ERYP
Esperion Therapeutics, Inc. Logo
Develops oral ACLY inhibitors to lower high LDL-C and cardiovascular risk.
United States of America
ESPR

Talk to a Data Expert

Have a question? We'll get back to you promptly.